Effective for dates of service on and after November 1, 2022, the specialty Medicare part B drugs listed in the table below will be included in our precertification review process.

 

Federal and state law, as well as state contract language and CMS guidelines, including definitions and specific contract provisions/exclusions, take precedence over these precertification rules and must be considered first when determining coverage. Noncompliance with new requirements may result in denied claims.

 

HCPCS or CPT® codes

Medicare part B drugs

C9098

Carvykti (ciltacabtagene autoleucel)

J3490

Carvykti (ciltacabtagene autoleucel)

J3590

Carvykti (ciltacabtagene autoleucel)

 

What if I need assistance?

If you have questions about this communication or need assistance with any other item, contact your local Provider Experience associate or call the number on the back of your patient’s AMH Health, LLC. member ID card.

 

MEAMH-CR-004063-22

 



Featured In:
September 2022 Anthem Maine Provider News